[
    {
        "text": "- A promising medical\nbreakthrough in the US",
        "start": 1.334,
        "duration": 1.001
    },
    {
        "text": "could save thousands\nof lives each year.",
        "start": 2.435,
        "duration": 2.036
    },
    {
        "text": "A new kind of cancer\ntreatment which",
        "start": 4.571,
        "duration": 1.534
    },
    {
        "text": "harnesses a patient's\nown immune system",
        "start": 6.205,
        "duration": 3.17
    },
    {
        "text": "cleared a big hurdle Wednesday.",
        "start": 9.475,
        "duration": 1.769
    },
    {
        "text": "If the drug is fully approved,\nit'll be the first gene",
        "start": 11.344,
        "duration": 3.437
    },
    {
        "text": "therapy on the market.",
        "start": 14.881,
        "duration": 2.102
    },
    {
        "text": "For more on this, we're\njoined by Jonathon Cohen.",
        "start": 17.083,
        "duration": 2.269
    },
    {
        "text": "He's an assistant\nprofessor in the Department",
        "start": 19.452,
        "duration": 1.601
    },
    {
        "text": "of Hematology and Oncology\nat Emory university's",
        "start": 21.153,
        "duration": 3.103
    },
    {
        "text": "School of Medicine.",
        "start": 24.356,
        "duration": 1.202
    },
    {
        "text": "Thank you so much\nfor being here.",
        "start": 25.658,
        "duration": 1.101
    },
    {
        "text": "We appreciate it.",
        "start": 26.859,
        "duration": 0.801
    },
    {
        "text": "JONATHON COHEN: My pleasure.",
        "start": 27.76,
        "duration": 1.101
    },
    {
        "text": "- I saw that one of the\ndoctors who voted in favor",
        "start": 28.961,
        "duration": 1.668
    },
    {
        "text": "of this treatment\ntold the \"Washington",
        "start": 30.729,
        "duration": 1.202
    },
    {
        "text": "Post\" that this is\nthe most exciting",
        "start": 32.031,
        "duration": 1.602
    },
    {
        "text": "thing I've seen in my lifetime.",
        "start": 33.733,
        "duration": 2.236
    },
    {
        "text": "Do explain to us\nhow this drug works",
        "start": 36.069,
        "duration": 1.868
    },
    {
        "text": "and why it's so promising.",
        "start": 38.037,
        "duration": 2.068
    },
    {
        "text": "JONATHON COHEN: So CAR-T\nis a group of new drugs",
        "start": 40.206,
        "duration": 2.736
    },
    {
        "text": "that are pretty\nremarkable actually.",
        "start": 43.042,
        "duration": 2.002
    },
    {
        "text": "They take the patient's\nown immune system.",
        "start": 45.144,
        "duration": 2.737
    },
    {
        "text": "They harvest T cells.",
        "start": 47.981,
        "duration": 1.501
    },
    {
        "text": "They then are manufactured\nand engineered in a way",
        "start": 49.582,
        "duration": 3.037
    },
    {
        "text": "that they then\nrecognize the cancer",
        "start": 52.719,
        "duration": 2.301
    },
    {
        "text": "and are infused back\ninto the patient,",
        "start": 55.12,
        "duration": 1.502
    },
    {
        "text": "where they then go and take\nout residual cancer cells.",
        "start": 56.722,
        "duration": 3.237
    },
    {
        "text": "And it's really hard\nto overstate the impact",
        "start": 60.059,
        "duration": 1.802
    },
    {
        "text": "that this new therapy will\nhave on a lot of patients.",
        "start": 61.961,
        "duration": 3.203
    },
    {
        "text": "- So how far is it in\nthe approval process?",
        "start": 65.265,
        "duration": 1.668
    },
    {
        "text": "Or in other words, when\nwill patients be able to get",
        "start": 67.033,
        "duration": 3.036
    },
    {
        "text": "it from their drugstores?",
        "start": 70.169,
        "duration": 2.302
    },
    {
        "text": "JONATHON COHEN: So this is a\ntype of therapy that especially",
        "start": 72.571,
        "duration": 2.236
    },
    {
        "text": "at the beginning will only\nbe available in specialized",
        "start": 74.907,
        "duration": 2.202
    },
    {
        "text": "centers, many of which\ncurrently participate",
        "start": 77.21,
        "duration": 3.369
    },
    {
        "text": "in bone marrow transplantation.",
        "start": 80.679,
        "duration": 1.669
    },
    {
        "text": "And many of those centers are\nalready offering this therapy",
        "start": 82.448,
        "duration": 2.269
    },
    {
        "text": "through clinical trials.",
        "start": 84.817,
        "duration": 1.402
    },
    {
        "text": "Our hope is that by later this\nyear some of these therapies",
        "start": 86.319,
        "duration": 2.502
    },
    {
        "text": "will be available outside\nof a clinical trial",
        "start": 88.921,
        "duration": 3.67
    },
    {
        "text": "when we receive FDA approval.",
        "start": 92.691,
        "duration": 1.535
    },
    {
        "text": "- What about eligibility?",
        "start": 94.326,
        "duration": 1.602
    },
    {
        "text": "I mean, does age affect just\nhow successful this treatment",
        "start": 96.028,
        "duration": 3.27
    },
    {
        "text": "could be, young versus older?",
        "start": 99.398,
        "duration": 1.669
    },
    {
        "text": "Is there an age limit?",
        "start": 101.167,
        "duration": 1.368
    },
    {
        "text": "JONATHON COHEN: So remarkably,\nwe've actually seen benefits",
        "start": 102.635,
        "duration": 1.869
    },
    {
        "text": "from these therapies\nin a wide age ranges",
        "start": 104.604,
        "duration": 2.168
    },
    {
        "text": "and across a number of\ndifferent cancer types.",
        "start": 106.873,
        "duration": 2.202
    },
    {
        "text": "So yesterday's meeting\ndiscussed a lot",
        "start": 109.175,
        "duration": 1.935
    },
    {
        "text": "about the effect\nin young patients",
        "start": 111.21,
        "duration": 2.235
    },
    {
        "text": "with acute\nlymphoblastic leukemia.",
        "start": 113.545,
        "duration": 1.77
    },
    {
        "text": "And that's really\nwhere we've seen some",
        "start": 115.415,
        "duration": 1.2
    },
    {
        "text": "of the most impressive results.",
        "start": 116.715,
        "duration": 1.669
    },
    {
        "text": "But we've also seen impressive\nresults in older patients,",
        "start": 118.484,
        "duration": 3.17
    },
    {
        "text": "including those that have\nnon-Hodgkin's lymphoma",
        "start": 121.754,
        "duration": 2.269
    },
    {
        "text": "and other cancer subtypes.",
        "start": 124.123,
        "duration": 1.034
    },
    {
        "text": "- So this could work as a cure?",
        "start": 125.257,
        "duration": 2.002
    },
    {
        "text": "JONATHON COHEN:\nSo it definitely,",
        "start": 127.359,
        "duration": 1.603
    },
    {
        "text": "in pediatric leukemia, appears\nto be a big step forward.",
        "start": 129.062,
        "duration": 3.636
    },
    {
        "text": "And there are many\npatients that were",
        "start": 132.798,
        "duration": 1.168
    },
    {
        "text": "on some of the\ninitial treatments",
        "start": 134.066,
        "duration": 1.134
    },
    {
        "text": "that remain in remission.",
        "start": 135.3,
        "duration": 1.302
    },
    {
        "text": "And many of those\npatients had no remaining",
        "start": 136.703,
        "duration": 2.235
    },
    {
        "text": "available treatment options.",
        "start": 139.038,
        "duration": 1.334
    },
    {
        "text": "So we always get nervous about\nthrowing around that word cure",
        "start": 140.472,
        "duration": 3.404
    },
    {
        "text": "because that's such\nan important word.",
        "start": 143.976,
        "duration": 1.301
    },
    {
        "text": "But this definitely appears\nto be a game changer",
        "start": 145.377,
        "duration": 2.069
    },
    {
        "text": "for a large number of patients.\n- A game changer.",
        "start": 147.546,
        "duration": 1.635
    },
    {
        "text": "And I guess it's too\nearly to say that this",
        "start": 149.281,
        "duration": 1.336
    },
    {
        "text": "could be a cure, right?",
        "start": 150.717,
        "duration": 1.2
    },
    {
        "text": "Because it's only been in\nclinical trials for so long.",
        "start": 152.017,
        "duration": 3.004
    },
    {
        "text": "JONATHON COHEN: Exactly.",
        "start": 155.121,
        "duration": 1.201
    },
    {
        "text": "It appears though\nto be very effective",
        "start": 156.422,
        "duration": 1.868
    },
    {
        "text": "in a large number of patients.",
        "start": 158.39,
        "duration": 1.002
    },
    {
        "text": "- Yeah.",
        "start": 159.492,
        "duration": 0.734
    },
    {
        "text": "A game changer is a big deal.",
        "start": 160.326,
        "duration": 1.301
    },
    {
        "text": "What about risks, though?",
        "start": 161.727,
        "duration": 1.001
    },
    {
        "text": "I mean for those--",
        "start": 162.828,
        "duration": 1.401
    },
    {
        "text": "things can still go wrong?",
        "start": 164.329,
        "duration": 1.836
    },
    {
        "text": "JONATHON COHEN: Yeah,\nso we've learned a lot",
        "start": 166.266,
        "duration": 2.201
    },
    {
        "text": "in our own institution\nand at other institutions",
        "start": 168.567,
        "duration": 1.869
    },
    {
        "text": "about how to manage some\nof the side effects.",
        "start": 170.536,
        "duration": 2.036
    },
    {
        "text": "But some patients can have\nlife threatening toxicity.",
        "start": 172.672,
        "duration": 2.636
    },
    {
        "text": "And so this is not a therapy\nthat we take lightly.",
        "start": 175.408,
        "duration": 2.735
    },
    {
        "text": "Any time that you rev\nup the immune system,",
        "start": 178.244,
        "duration": 2.603
    },
    {
        "text": "you can stimulate inflammation\nthroughout the body,",
        "start": 180.947,
        "duration": 2.402
    },
    {
        "text": "which can lead to life\nthreatening complications.",
        "start": 183.449,
        "duration": 2.837
    },
    {
        "text": "And we've also seen\nsome significant",
        "start": 186.386,
        "duration": 1.4
    },
    {
        "text": "neurologic toxicity.",
        "start": 187.886,
        "duration": 1.436
    },
    {
        "text": "- I see.",
        "start": 189.422,
        "duration": 0.733
    },
    {
        "text": "But why leukemia patients?",
        "start": 190.255,
        "duration": 1.469
    },
    {
        "text": "Are they best suited\nto have the most",
        "start": 191.824,
        "duration": 3.77
    },
    {
        "text": "effectiveness out of this drug?",
        "start": 195.694,
        "duration": 1.435
    },
    {
        "text": "JONATHON COHEN: So we're\nactually investigating the drug",
        "start": 197.229,
        "duration": 1.802
    },
    {
        "text": "in a number of\nsubtypes, but leukemia",
        "start": 199.131,
        "duration": 1.768
    },
    {
        "text": "was one of the first to be\ninvestigated because we were",
        "start": 200.999,
        "duration": 2.436
    },
    {
        "text": "able to generate a product\ntargeting a specific marker",
        "start": 203.535,
        "duration": 3.872
    },
    {
        "text": "on the leukemia cells.",
        "start": 207.507,
        "duration": 1.634
    },
    {
        "text": "So this first generation\nof CAR-T cells",
        "start": 209.241,
        "duration": 1.602
    },
    {
        "text": "targets something called\nCD19, which is typically",
        "start": 210.944,
        "duration": 3.269
    },
    {
        "text": "present in patients that have\nacute lymphoblastic leukemia",
        "start": 214.313,
        "duration": 2.603
    },
    {
        "text": "and other types of\nnon-Hodgkin's lymphoma.",
        "start": 217.016,
        "duration": 1.802
    },
    {
        "text": "- Wow.",
        "start": 218.918,
        "duration": 1.101
    },
    {
        "text": "Really impressive, and\nobviously really exciting,",
        "start": 220.119,
        "duration": 1.635
    },
    {
        "text": "especially for cancer patients.",
        "start": 221.854,
        "duration": 1.935
    },
    {
        "text": "We appreciate you joining\nus, Jonathon Cohen.",
        "start": 223.889,
        "duration": 1.535
    },
    {
        "text": "Thank you.",
        "start": 225.525,
        "duration": 0.734
    },
    {
        "text": "JONATHON COHEN: My pleasure.",
        "start": 226.359,
        "duration": 0.5
    },
    {
        "text": "Thank you.",
        "start": 226.96,
        "duration": 1.0
    }
]